Literature DB >> 25636877

Antiosteoporotic activity and constituents of Podocarpium podocarpum.

Qi Ye1, Xue-Qin Ma2, Chang-Ling Hu3, Bing Lin3, Li-Sheng Xu4, Cheng-Jian Zheng5, Lu-Ping Qin6.   

Abstract

Our study aimed to investigate the antiosteoporotic properties of the ethanol extract of Podocarpium podocarpum (DC.) Yang et Huang (PE) in ovariectomized (OVX) rats and to characterize the active constituents. As a result, PE significantly inhibited the increased urinary Ca excretion and activity of bone resorption markers including tartrate-resistant acid phosphatase (TRAP), deoxypyridinoline crosslinks and cathepsin K in OVX rats, whereas exhibited little effects on the body, uterus and vagina weight. Detailed micro-CT analysis showed that PE notably enhanced bone quality, with increased bone mineral content (BMC), bone volume fraction (BVF), connectivity density (CD), tissue mineral content (TMC), tissue mineral density (TMD) and trabecular number (Tb. N), and decreased trabecular separation (Tb. Sp), in OVX animal. Those findings implied that PE had notable antiosteoporotic effect, especially effective in preventing bone resorption, with little side-effects on reproductive tissue. Further chemical investigation led to the isolation of 17 flavonoids, most of which showed significantly stimulatory effect on osteoblastic proliferation, ALP activity and mineralized nodes formation as well as inhibitory effect on osteoclastic TRAP activity in osteoblastic and osteoclastic cells. Our results indicated that PE, with abundant flavonoids, had remarkable antiosteoporotic activity and therefore can be a promising candidate for the treatment of postmenopausal osteoporosis induced by estrogen deficiency through herbal remedy.
Copyright © 2014 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Antiosteoporotic; Flavonoids; Osteoblast; Osteoclast; Podocarpium podocarpum

Mesh:

Substances:

Year:  2014        PMID: 25636877     DOI: 10.1016/j.phymed.2014.11.004

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  7 in total

1.  An experimental research into the potential therapeutic effects of Anti-Osteoporosis Decoction and Yougui Pill on ovariectomy-induced osteoporosis.

Authors:  Fulong Gu; Jiang Jiang; Sheng Wang; Tao Feng; Yi Zhou; Yong Ma; Shuijie Shen
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  The Brown Algae Ishige sinicola Extract Ameliorates Ovariectomy-Induced Bone Loss in Rats and Suppresses Osteoclastogenesis through Downregulation of NFATc1/c-Fos.

Authors:  Mihyang Kim; Mihwa Park
Journal:  Nutrients       Date:  2022-04-19       Impact factor: 6.706

Review 3.  Natural Products from Chinese Medicines with Potential Benefits to Bone Health.

Authors:  Chun-Tao Che; Man Sau Wong; Christopher Wai Kei Lam
Journal:  Molecules       Date:  2016-02-27       Impact factor: 4.411

4.  Therapeutic Effect of Cistanoside A on Bone Metabolism of Ovariectomized Mice.

Authors:  Xiaoxue Xu; Zhuanzhuan Zhang; Wenping Wang; Huiqin Yao; Xueqin Ma
Journal:  Molecules       Date:  2017-01-24       Impact factor: 4.411

5.  Effect of Black Tea Extract and Thearubigins on Osteoporosis in Rats and Osteoclast Formation in vitro.

Authors:  Qingqing Liang; Ming Lv; Xiaojuan Zhang; Jun Hu; Ying Wu; Yewei Huang; Xuanjun Wang; Jun Sheng
Journal:  Front Physiol       Date:  2018-09-03       Impact factor: 4.566

6.  Anti-Osteoporotic Activity of an Edible Traditional Chinese Medicine Cistanche deserticola on Bone Metabolism of Ovariectomized Rats Through RANKL/RANK/TRAF6-Mediated Signaling Pathways.

Authors:  Bo Zhang; Ling-Ling Yang; Shu-Qin Ding; Jing-Jing Liu; Yan-Hong Dong; Yan-Ting Li; Nan Li; Xiao-Jun Zhao; Chang-Ling Hu; Yiping Jiang; Xue-Qin Ma
Journal:  Front Pharmacol       Date:  2019-11-26       Impact factor: 5.810

7.  Dendrobium officinale Orchid Extract Prevents Ovariectomy-Induced Osteoporosis in Vivo and Inhibits RANKL-Induced Osteoclast Differentiation in Vitro.

Authors:  Qi Wang; Cheng-Ting Zi; Jing Wang; Yu-Na Wang; Ye-Wei Huang; Xue-Qi Fu; Xuan-Jun Wang; Jun Sheng
Journal:  Front Pharmacol       Date:  2018-01-15       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.